Engineering the Lymph Node Environment with Therapeutic Vaccine Depots to Combat Neuroblastoma |
University of Maryland, College Park / Christopher Jewell, PhD |
'A' Award Grants |
2013 |
Maryland |
Investigating the Role of Genetic and Epigenetic Variation in Risk of Childhood Acute Lymphoblastic Leukemia in Down Syndrome |
University of California San Francisco / Adam de Smith, Ph.D. |
'A' Award Grants |
2014 |
California |
Uncovering the Dysregulated RNA Binding Protein Network in Childhood Acute Myeloid Leukemia |
Memorial Sloan-Kettering Cancer Center / Michael Kharas, PhD |
'A' Award Grants |
2016 |
New York |
Inside-Out Immunotherapy: Combating Neuroblastoma via Nanoparticle-Directed Reprogramming of the Tumor Microenvironment |
Vanderbilt University Medical Center / John Wilson, PhD |
'A' Award Grants |
2015 |
Tennessee |
A Combinatorial Approach to Target the Tumor-Initiating and Transit Amplifying Cellular Subpopulations in Diffuse Intrinsic Pontine Glioma (DIPG) |
Stanford University / Michelle Monje, MD, PhD |
'A' Award Grants |
2011 |
California |
Novel Approaches to AML Differentiation Therapy |
Dana-Farber Cancer Institute / Andrew Lane, MD/PhD |
'A' Award Grants |
2017 |
Massachusetts |
A Cell Morphology Landscape of Pediatric Cancer Cell Lines |
University of Colorado Denver_ Anschutz Medical Campus / Gregory Way, PhD |
'A' Award Grants |
2023 |
Colorado |
Elucidating the Role of SETD2 in Pediatric High Grade Glioma Formation |
Children’s Hospital of Philadelphia / Thomas De Raedt, PhD |
'A' Award Grants |
2019 |
Pennsylvania |
Unraveling the Function of PAX3-FOXO1’s Activation Domain in Rhabdomyosarcoma |
Case Western Reserve University / Berkley Gryder, PhD |
'A' Award Grants |
2023 |
Ohio |
Genomic and nuclear organizational changes in chemotherapy-resistant rhabdomyosarcoma cells |
Ann & Robert H. Lurie Children’s Hospital of Chicago / Kyle MacQuarrie, MD/PhD |
'A' Award Grants |
2023 |
Illinois |